Sequential combination chemotherapy for malignant germ cell tumors of the ovary

Josep R. Germa, Josep M. Piera, Agusti Barnadas, Josep Badia

    Research output: Contribution to journalArticleResearchpeer-review

    17 Citations (Scopus)

    Abstract

    Fourteen patients with malignant ovarian germ cell tumors were treated postoperatively with a short‐term, sequential regimen combining cisplatin, vincristine, methotrexate, bleomycin, dactinomycin, cyclophosphamide, etoposide, Adriamycin (Adria Laboratories, Columbus, OH), and vinblastine (POMB/ACE/PAV). Two patients had Stage I disease, Five had Stage II, five had Stage III, and two had Stage IV. The histologic diagnosis was immature teratoma in five cases (two cases were Grade 2 and three cases were Grade 3) endodermal sinus tumor in two cases, dysgeminoma in three cases, and mixed germ cell tumors in four cases. The chemotherapy regimen appeared to be highly effective against all histologic types, including advanced stages, with 12 of 14 (86%) overall sustained remissions. The median duration of treatment was 5 months. The toxicity of the regimen, which contained low total doses of cisplatin and bleomycin, was only moderate. After a median follow‐up of 53+ months, 13 patients were alive without evidence of disease. The results and toxicity obtained were compared with those from other currently used regimens. Also, some comments on initial surgery and second‐look surgery are given. Copyright © 1988 American Cancer Society
    Original languageEnglish
    Pages (from-to)913-918
    JournalCancer
    Volume61
    Issue number5
    DOIs
    Publication statusPublished - 1 Jan 1988

    Fingerprint

    Dive into the research topics of 'Sequential combination chemotherapy for malignant germ cell tumors of the ovary'. Together they form a unique fingerprint.

    Cite this